View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pertuzumab 420 / Trastuzumab 6, Salivary Gland Tumor, Cycle 2+
Protocol-ID: 1702 V1.1 (Mini), PERT420/TRAS6, Salivary Gland Tumor, C2+Indication(s)
- Salivary Gland Tumor (HER2+); ICD-10 C08.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.01.2022